welbournes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Formoterol (Oxis® 6 Turbohaler) 6micrograms/dose dry powder inhaler. MSN/2024/018 Tier 2 – medium impact Date of issue: 12th February 2024 Formoterol (Oxis® 6 Turbohaler) 6micrograms/dose dry powder inhalers are out of stock until mid March 2024. Formoterol (Oxis® 12 Turbohaler) 12micrograms/dose [...]

The post Medicine Supply Notification: Formoterol (Oxis® 6 Turbohaler) 6micrograms/dose dry powder inhaler appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxcarbazepine 150mg and 300mg tablets. MSN/2024/016 Tier 2 – medium impact Date of issue 8th February 2024 Oxcarbazepine 150mg tablets (Viatris) are out of stock until late March 2024 Oxcarbazepine 150mg tablets (Trileptal®) remain available, however, cannot support the full increase [...]

The post Medicine Supply Notification: Oxcarbazepine 150mg and 300mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nadolol 80mg tablets MSN/2024/015 Tier 2 – medium impact Date of issue 8th February 2024 Nadolol 80mg tablets are out of stock from early March until early May 2024. Alternative beta-blockers remain available and can support increase demand. Where these are [...]

The post Medicine Supply Notification: Nadolol 80mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Flixotide® (fluticasone) 50 micrograms/dose Evohaler MSN/2024/014 Tier 2 – medium impact Date of issue: 8th February 2024 Flixotide® (fluticasone) 50 micrograms/dose Evohaler is out of stock until early March 2024. Flixotide® (fluticasone) 50 micrograms/dose Accuhaler remains available and can support a [...]

The post Medicine Supply Notification: Flixotide® (fluticasone) 50 micrograms/dose Evohaler appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) Drug alert number: EL (24)A/04 Date issued: 01 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Gepretix 100mg Capsules (Exeltis UK Limited) Company name: Exeltis UK Limited Product name: Gepretix 100mg Capsules, [...]

The post MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) appeared first on Community Pharmacy England.